Anapharm provides a wide range of early-phase drug development services to the pharmaceutical, biopharmaceutical and generic industries. These include Phase I, bioequivalence, clinical pharmacology, regulatory and a vast array of bioanalytical services. Anapharm was acquired by SFBC International, now PharmaNet, in 2002.